Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The NIMA-related kinase 2 pseudogene is a non-functional genomic sequence with similarity to the protein-coding NEK2 gene. Unlike NEK2, which encodes an active serine/threonine kinase involved in mitotic regulation and cell cycle control[1][4][10], this pseudogene does not produce a functional protein and has no known therapeutic, biological, or disease relevance. Pseudogenes arise through gene duplication or retrotransposition events followed by accumulation of disabling mutations[3]. As such, the "NIMA-related kinase 2 pseudogene" is not a receptor, enzyme, transporter, or any functional drug target. Its presence in the genome serves primarily as a record of evolutionary history without current known significance to disease or therapy. Key clarification: If your intention was to explore the drug target NEK2 or “NIMA-related kinase 2,” you should use its protein-coding gene entry (e.g., ENSG00000117650, NEK2), not the pseudogene[8][4][9]. The pseudogene entry ENSG00000274649 is not a valid therapeutic or biological target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NIMA-related kinase 2 pseudogene.